Location: Home
  • search
  • go
  • Relate News
  • 6/28/2021WuXi STA Plans Pharmaceutical Chemical Facility in Delaware
  • 6/28/2021InnoCare Announces Breakthrough Therapy Designation of Orelabrutinib b...
  • 6/28/2021J&J Partner Legend Plans JV Facility in Belgium as Its CAR-T Cilta-cel...
  • 6/28/2021Innovent Announces License Agreement with Synaffix in an ADC Technolog...
  • 6/28/2021Lonza Invests in Facility in China
  • 6/28/2021Junshi Biosciences Announces NMPA Acceptance of IND Application for JS...
  • 6/28/2021PharmaDJ's China Biotech Fundraising Tracker: April 2021
  • 6/28/2021Latest Developments on Data Supplementation for Chemical or Pharmaceut...
  • 6/25/2021AZ's Pulmicort, Bayer's Xarelto Among Big Losers in China's Largest Ro...
  • 6/25/2021Innovent Releases Results of a Phase 1 Clinical Study of IBI362 in Ove...
  • 6/25/2021NMPA Issues the List of Reference Formulations for GQCE Studies (42nd ...
  • 6/25/2021CDE Issues the Technical Guidelines for Pharmaceutic Change Studies of...
  • 6/24/2021CStone Announces Positive GAVRETO (Pralsetinib) Registrational Study D...
  • 6/24/2021NMPA Issues the Provisions for Registration of Licensed Pharmacists
  • 6/24/2021China Concludes the 5th Round of National Level VBP, Slashing Average ...
  • 6/24/2021NMPA Revises Packages Insert of Oxiracetam Formulations and Injectable...
  • 6/24/2021CDE's Annual Review of Chinese Drug Evaluation and Registration in 202...
  • 6/24/2021Pharmaceuticals and APIs - Biden Admin Issues 100-Day Supply Chain Rev...
  • 6/23/2021Online Platform Operator Medlive Tech Advances Plans for Hong Kong IPO
  • 6/23/2021HUTCHMED's Orpathys Conditionally Approved in China for NSCLC
  • 6/23/2021Innovent's Sintilimab in Combo with Chemotherapy Meets Primary Endpoin...
  • 6/23/2021CDE Solicits Comments on the Work Procedures for Changes During Drug R...
  • 6/22/2021OPKO Health to Develop and Commercialize CKD Drug RAYALDEE in Greate...
  • 6/22/2021BeiGene Granted Chinese Conditional Approval of Zanubrutinib r/r Walde...
  • 6/22/2021Innovent's Pemazyre (pemigatinib) Approved in Taiwan
  • 6/22/2021Hutchmed Granted Chinese Approval of Surufatinib (Sulanda) for Advance...
  • 6/22/2021CDE Issues the Guide to Biological Product Change Acceptance Review (I...
  • 6/22/2021China NMPA Approves Tislelizumab in Non-Small Cell Lung Cancer and Hep...
  • 6/22/2021China Grants First CAR-T Cell Therapy Approval to Gilead JV Fosun-Kit...
  • 6/22/2021Big Questions Remain over China's Patent Linkage System
  • Page:181/774 Total number of articles:23208: [First][<<] [179] [180] [181] [182] [183] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group